Stroke research and treatment
Kahle MP, Bix GJ.
PMID: 23326759
Stroke Res Treat. 2012;2012:374098. doi: 10.1155/2012/374098. Epub 2012 Dec 30.
The Stroke Therapy Academic Industry Roundtable (STAIR) provided initial (in 1999) and updated (in 2009) recommendations with the goal of improving preclinical stroke therapy assessment and to increase the translational potential of experimental stroke treatments. It is important for...
Cite
Kahle MP, Bix GJ. Successfully Climbing the "STAIRs": Surmounting Failed Translation of Experimental Ischemic Stroke Treatments. Stroke Res Treat. 2012;2012:374098doi: 10.1155/2012/374098.
Kahle, M. P., & Bix, G. J. (2012). Successfully Climbing the "STAIRs": Surmounting Failed Translation of Experimental Ischemic Stroke Treatments. Stroke research and treatment, 2012374098. https://doi.org/10.1155/2012/374098
Kahle, Michael P, and Bix, Gregory J. "Successfully Climbing the "STAIRs": Surmounting Failed Translation of Experimental Ischemic Stroke Treatments." Stroke research and treatment vol. 2012 (2012): 374098. doi: https://doi.org/10.1155/2012/374098
Kahle MP, Bix GJ. Successfully Climbing the "STAIRs": Surmounting Failed Translation of Experimental Ischemic Stroke Treatments. Stroke Res Treat. 2012;2012:374098. doi: 10.1155/2012/374098. Epub 2012 Dec 30. PMID: 23326759; PMCID: PMC3544313.
Copy
Download .nbib
Frontiers in pharmacology
Roberts J, Kahle MP, Bix GJ.
PMID: 22936915
Front Pharmacol. 2012 Aug 23;3:155. doi: 10.3389/fphar.2012.00155. eCollection 2012.
The cerebral microvasculature is important for maintaining brain homeostasis. This is achieved via the blood-brain barrier (BBB), composed of endothelial cells with specialized tight junctions, astrocytes, and a basement membrane (BM). Prominent components of the BM extracellular matrix (ECM)...
Cite
Roberts J, Kahle MP, Bix GJ. Perlecan and the blood-brain barrier: beneficial proteolysis?. Front Pharmacol. 2012;3:155doi: 10.3389/fphar.2012.00155.
Roberts, J., Kahle, M. P., & Bix, G. J. (2012). Perlecan and the blood-brain barrier: beneficial proteolysis?. Frontiers in pharmacology, 3155. https://doi.org/10.3389/fphar.2012.00155
Roberts, Jill, et al. "Perlecan and the blood-brain barrier: beneficial proteolysis?." Frontiers in pharmacology vol. 3 (2012): 155. doi: https://doi.org/10.3389/fphar.2012.00155
Roberts J, Kahle MP, Bix GJ. Perlecan and the blood-brain barrier: beneficial proteolysis?. Front Pharmacol. 2012 Aug 23;3:155. doi: 10.3389/fphar.2012.00155. eCollection 2012. PMID: 22936915; PMCID: PMC3425914.
Copy
Download .nbib
